Skip to main content
Clinical Trials/CTRI/2018/08/015457
CTRI/2018/08/015457
Recruiting
未知

A Non-Interventional, Multicenter, Prospective, Observational Study to Understand Usage and EFFect of Teneligliptin as Monotherapy OR Add On Treatment in Indian Type 2 Diabetes Patients on other Antidiabetic Drugs (AFFORD Study) - AFFORD

Torrent Pharmaceuticals Ltd0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: null- Type 2 Diabetes Mellitus
Sponsor
Torrent Pharmaceuticals Ltd
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Patient willing to provide informed consent
  • 2\. Female or male patient aged 18 years or above
  • 3\. Treatment naïve adult patients or adult patients who had inadequately controlled type 2 diabetes mellitus despite using diet plus exercise and/or OADs:
  • a. HbA1C greater than 6\.5%
  • b. FBG greter than or equal to 140 mg/dL
  • 4\. Requirement for teneligliptin as a monotherapy or add\-on
  • 5\. Patients must provide written consent to use personal and/or health data prior to the entry into the study

Exclusion Criteria

  • 1\. Patients with Type 1 diabetes mellitus
  • 2\. Patient on DPP 4 inhibitor other than teneligliptin and GLP 1 analogue therapy
  • 3\. Any medical condition of the patient which in opinion of Investigator would interfere with safe completion of the study
  • 4\. Pregnant and lactating woman
  • 5\. Women of child bearing potential not ready to use an effective barrier contraceptive method during the study
  • 6\. Patients participating in any other clinical trials

Outcomes

Primary Outcomes

Not specified

Similar Trials